Key regions: China, Europe, Australia, United States, Germany
The Other Pharmaceuticals market in Colombia has been experiencing growth in recent years.
Customer preferences: Colombian consumers have been showing a growing interest in natural remedies and alternative medicine. This trend has led to an increase in demand for herbal and homeopathic remedies, as well as dietary supplements. Consumers are also becoming more health-conscious and are willing to pay a premium for products that are perceived to be healthier.
Trends in the market: The Other Pharmaceuticals market in Colombia has been growing due to a combination of factors. The aging population is driving demand for pharmaceutical products, while the rising middle class is increasing the overall purchasing power of consumers. Additionally, the government has been investing in healthcare infrastructure, which has led to an increase in access to healthcare services.One of the key trends in the market is the increasing popularity of generic drugs. As healthcare costs continue to rise, consumers are looking for more affordable options. Generic drugs are typically less expensive than their branded counterparts, and they are becoming more widely available in Colombia.Another trend in the market is the growing importance of e-commerce. Many consumers are now purchasing pharmaceutical products online, which is driving growth in the online retail sector. This trend is expected to continue in the coming years as more consumers become comfortable with online shopping.
Local special circumstances: One of the unique aspects of the Colombian market is the prevalence of informal pharmacies. These are small, independently owned pharmacies that are not licensed by the government. While these pharmacies are not subject to the same regulations as licensed pharmacies, they are still popular among consumers due to their convenience and lower prices.
Underlying macroeconomic factors: Colombia has been experiencing steady economic growth in recent years, which has helped to drive growth in the Other Pharmaceuticals market. Additionally, the government has been investing in healthcare infrastructure, which has led to an increase in access to healthcare services. However, political instability and violence in certain parts of the country continue to pose a risk to the overall economy.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
